Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Petr, Pavlicek"'
Autor:
Viera Sandecka, Tereza Popkova, Martin Stork, Vladimir Maisnar, Jiri Minarik, Alexandra Jungova, Petr Pavlicek, Lukas Stejskal, Lenka Pospisilova, Adriana Heindorfer, Jarmila Obernauerova, Evzen Gregora, Michal Sykora, Jana Ullrychova, Marek Wrobel, Petr Kessler, Tomas Jelinek, Peter Kunovszki, Sacheeta Bathija, Blanca Gros, Sabine Wilbertz, Qian Cai, Annette Lam, Ivan Spicka
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Smoldering multiple myeloma (SMM) is an asymptomatic precursor to active multiple myeloma (MM). The aim of this study was to report clinical characteristics and outcomes of patients with SMM stratified based on their risk of progression to M
Externí odkaz:
https://doaj.org/article/ac4fa0e66df54bf9a47e4350692f9954
Autor:
Barbora Vakrmanova, Ester Mejstrikova, Jakub Jonas, Petr Pavlicek, Marketa Zaliova, Marek Turnovec, Livia Molcanyova, Eva Fronkova, Ondrej Hrusak, Lucie Sramkova
Publikováno v:
EJC Paediatric Oncology, Vol 2, Iss , Pp 100097- (2023)
Externí odkaz:
https://doaj.org/article/f1d3a468adbf424eb4f3915dbbb7214b
Autor:
Jiri Minarik, Tomas Pika, Jakub Radocha, Alexandra Jungova, Jan Straub, Tomas Jelinek, Ludek Pour, Petr Pavlicek, Martin Mistrik, Lucie Brozova, Petra Krhovska, Katerina Machalkova, Pavel Jindra, Ivan Spicka, Hana Plonkova, Martin Stork, Jaroslav Bacovsky, Lenka Capkova, Michal Sykora, Petr Kessler, Lukas Stejskal, Adriana Heindorfer, Jana Ullrychova, Tomas Skacel, Vladimir Maisnar, Roman Hajek
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background We have performed a head to head comparison of all-oral triplet combination of ixazomib, lenalidomide and dexamethasone (IRD) versus lenalidomide and dexamethasone (RD) in patients with relapsed and refractory multiple myeloma (RR
Externí odkaz:
https://doaj.org/article/f4b149c2be57476793d1f90b53292d39
Autor:
Martin Stork, Sabina Sevcikova, Tomas Jelinek, Jiri Minarik, Jakub Radocha, Tomas Pika, Lenka Pospisilova, Ivan Spicka, Jan Straub, Petr Pavlicek, Alexandra Jungova, Zdenka Knechtova, Viera Sandecka, Vladimir Maisnar, Roman Hajek, Ludek Pour
Publikováno v:
Biomedicines, Vol 10, Iss 10, p 2535 (2022)
In multiple myeloma (MM), malignant plasma cells infiltrate the bone marrow. In some cases, plasma cells migrate out of the bone marrow creating either para-skeletal plasmacytomas (PS) or infiltrating soft tissues as extramedullary plasmacytomas (EMD
Externí odkaz:
https://doaj.org/article/e364609dd50643da92cbb311d623a43f
Autor:
Adam Klocperk, Zuzana Parackova, Jitka Dissou, Hana Malcova, Petr Pavlicek, Tomas Vymazal, Pavla Dolezalova, Anna Sediva
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
We report a case of an 8-year-old girl who underwent a SARS-CoV-2 infection manifesting with atypical symptoms spearheaded by abdominal discomfort and systemic inflammation and partially mimicking hemophagocytic lymphohistiocytosis (HLH) or macrophag
Externí odkaz:
https://doaj.org/article/db709ac1c28f4ee5b32e9c1c2bfc464d
Autor:
Martin Stork, Ivan Spicka, Jakub Radocha, Jiri Minarik, Tomas Jelinek, Alexandra Jungova, Petr Pavlicek, Lenka Pospisilova, Frantisek Sedlak, Jan Straub, Tomas Pika, Zdenka Knechtova, Anna Fidrichova, Ivanna Boichuk, Sabina Sevcikova, Vladimir Maisnar, Roman Hajek, Ludek Pour
Publikováno v:
Annals of Hematology
We performed real world evidence (RWE) analysis of daratumumab, lenalidomide and dexamethasone (Dara-Rd) versus lenalidomide and dexamethasone (Rd) treatment in relapsed/refractory multiple myeloma patients (RRMM). In total, 240 RRMM patients were tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84d71d7e55cadb3d6c314ad8aec76958
https://is.muni.cz/publication/2278163
https://is.muni.cz/publication/2278163
Autor:
Tomas Jelinek, Jiri Minarik, Ivan Spicka, Petra Krhovska, Viera Sandecká, Martin Stork, Ludek Pour, Jan Straub, Sabina Ševčíková, Petr Pavlicek, Alexandra Jungova, Jakub Radocha, Roman Hájek, Lucie Brozova, Jiri Jarkovsky, Vladimir Maisnar, Lenka Pospisilova
Publikováno v:
British Journal of Haematology. 196:954-962
Multiple myeloma (MM) is characterized by malignant plasma cell infiltration of the bone marrow. In extramedullary multiple myeloma (EMD), a subclone of these cells migrates out of the bone marrow. Out of 4 985 MM patients diagnosed between 2005 and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f305787dc8dca12c201069702c56d2b
https://doi.org/10.1111/bjh.17925
https://doi.org/10.1111/bjh.17925
Autor:
Michal Sýkora, Lukas Stejskal, Alexandra Jungova, Vladimir Maisnar, Petr Kessler, Viera Sandecká, Jana Ullrychova, Adriana Heindorfer, Luděk Pour, Tomas Pika, Jan Straub, Martin Stork, Jiří Minařík, Lucie Brožová, Roman Hájek, Ivan Spicka, Tomas Jelinek, Petr Pavlicek, David Starostka, Sabina Ševčíková, Jakub Radocha, Marek Wrobel
Publikováno v:
European Journal of Haematology. 107:466-474
Objectives This study compared the use of bortezomib in different combination regimens in newly diagnosed multiple myeloma (NDMM) patients who were transplant ineligible. Patients and methods We analyzed data from the Registry of Monoclonal Gammopath
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e1c1a0103ebd62cfdd0ad071e031465
https://doi.org/10.1111/ejh.13683
https://doi.org/10.1111/ejh.13683
Autor:
Lucie Rihova, David Zihala, Michal Simicek, Tereza Sevcikova, Tomas Jelinek, Alexandra Jungova, Vladimir Maisnar, Veronika Kapustová, Roman Hájek, Lucie Broskevicova, Tereza Popkova, Ludek Pour, Petr Pavlicek, Ivan Spicka, Lenka Capkova, Hana Plonkova, Martin Stork, Renata Bezdekova, Jiri Minarik, Martin Havel, Vladimir Zidlik, Sabina Ševčíková, Jakub Radocha
Publikováno v:
Leukemia. 36:288-291
The treatment of multiple myeloma (MM) has changed substantially during the past two decades. The incorporation of novel agents into therapeutic strategies has resulted in prolonged overall survival of MM patients with approximately 15% of them being
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c642738d4faa696b2a7a51b91d9fb4ec
https://doi.org/10.1038/s41375-021-01343-w
https://doi.org/10.1038/s41375-021-01343-w
Autor:
Katerina Machalkova, Roman Hájek, Alexandra Jungova, Tomas Skacel, Jaroslav Bacovsky, Petr Kessler, Vladimir Maisnar, Jakub Radocha, Michal Sykora, Tomas Pika, Tomas Jelinek, Martin Stork, Petr Pavlicek, Lucie Brozova, Martin Mistrik, Hana Plonkova, Jan Straub, Jana Ullrychova, Adriana Heindorfer, Lukas Stejskal, Ivan Spicka, Lenka Capkova, Pavel Jindra, Ludek Pour, Jiri Minarik, Petra Krhovska
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-13 (2021)
BMC Cancer
BMC Cancer
Background We have performed a head to head comparison of all-oral triplet combination of ixazomib, lenalidomide and dexamethasone (IRD) versus lenalidomide and dexamethasone (RD) in patients with relapsed and refractory multiple myeloma (RRMM) in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b08d5e441b52c7474193c21fd6298af
https://doaj.org/article/f4b149c2be57476793d1f90b53292d39
https://doaj.org/article/f4b149c2be57476793d1f90b53292d39